Trials / Completed
CompletedNCT01168310
A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
A 12-week Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Pharmacodynamic Response of Fluticasone Propionate in Fixed-Dose Combination With Formoterol Fumarate in Subjects With COPD
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 468 (actual)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 40 Days
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, multi-dose, parallel group trial which will assess the pharmacodynamic response of fluticasone propionate and formoterol fumarate in subjects with COPD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluticasone Propionate/Formoterol Fumarate | Inhalation Suspension |
| DRUG | Fluticasone Propionate/Formoterol Fumarate | Inhalation Suspension |
| DRUG | Fluticasone Propionate/Formoterol Fumarate | Inhalation Suspension |
| DRUG | Fluticasone Propionate/Formoterol Fumarate | Inhalation Suspension |
| DRUG | Fluticasone Propionate/Formoterol Fumarate | Inhalation Suspension |
| DRUG | Formoterol Fumarate | Inhalation Solution |
| DRUG | Placebo | Inhalation Solution |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2010-08-01
- Completion
- 2011-10-01
- First posted
- 2010-07-23
- Last updated
- 2013-05-27
Locations
23 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01168310. Inclusion in this directory is not an endorsement.